Tag: licensing

Looney Tunes™ Land Now Open at Six Flags Magic Mountain

Complete reimagining of the park's family area offers a brand-new experience that encourages exploration across four distinct areas with loveable Looney Tunes™ characters at its heartLooney...

New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight...

Press release – No. 13 / 2026

SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281VANCOUVER, BC, June 5, 2026 /PRNewswire/ -- Synbio Tech Inc. (SynbioTech),...

The Finnish Financial Supervisory Authority has granted Ahlstrom Capital B.V. and A. Ahlström Oy as well as Erkki Etola, Etola Group Oy and Oy...

Suominen Corporation’s stock exchange release on June 5, 2026, at 12:00 p.m. (EEST)

The Inner Circle acknowledges Susan Ray-Degges as a Pinnacle Professional Member Inner Circle of Excellence

FARGO, N.D., June 4, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Susan Ray-Degges is acknowledged as a Pinnacle Professional Member Inner Circle...

STUDIO 55 BRINGS BRAND AND BROADCAST PARTNERS TOGETHER FOR TRANSATLANTIC LOVE ISLAND PARTNERSHIP WITH POPPI

Peacock and ITV Develop In-Show Placements for Love Island USA and UK Studio 55 Extends poppi Partnership To USA Retail & UK Experiences,Plans For...

Ocean Tomo, a Part of J.S. Held, Experts Named to the 2026 IAM Patent 1000

Intellectual Property disputes professionals named among the world's top experts by IAM.NEW YORK, June 4, 2026 /PRNewswire/ -- The 2026 IAM Patent 1000 has once...

LanzaTech JV Successful IPO Underscores Strategic Value of More Secure Fuel Supply

SKOKIE, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, announced that Beijing Shougang LanzaTech Technology Co., Ltd., (the “JV”), a joint venture in which LanzaTech held a 9.31% equity stake prior to the offering described below, has launched its Initial Public Offering (IPO) of 40 million H-Shares at a public offering price equivalent to approximately US$1.86 per share, based on applicable exchange rates, on the Hong Kong Stock Exchange. The offering raised gross proceeds of approximately US$75M before underwriting discounts and commissions.

Benzinga Enhances Stake Platform With Real-Time Market Catalyst Insights

DETROIT and SYDNEY, June 4, 2026 /PRNewswire/ -- Benzinga, a leading provider of real-time financial news and market intelligence, today announced that Stake has...

X-energy Reports First Quarter 2026 Results

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

Zhihu Inc. Reports Unaudited First Quarter 2026 Financial Results

BEIJING, China, June 03, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended March 31, 2026.

Figure Technology Solutions Reports May 2026 Operating Data

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale, and trading of tokenized assets, today reported select preliminary operating data for the month ended May 31, 2026.

Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026...

- The INDIGO study met its primary and all key secondary endpoints with statistically significant results -

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsLicensing

SK Telecom and NVIDIA Build AI Infrastructure to Power Korea’s AI Innovation

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PHR

Canadian Employers Invited to Create 10,000 New Opportunities Through National Inclusive Hiring Campaign